My watch list
my.chemeurope.com  
Login  

1,349 Current news from the ressort products

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

SYMBICORT® GAINS EUROPEAN UNION MUTUAL RECOGNITION APPROVAL FOR ASTHMA CONTROL

08-Jan-2001

AstraZeneca announced today that Symbicort®, a new and innovative treatment for asthma, has been granted approval through the Mutual Recognition Procedure (MRP) in 14 European Union (EU) states plus Norway and Iceland. This follows initial approval of Symbicort® in Sweden in August 2000. ...

more

NuGenesis® Technologies and Quality Systems International (QSI) Announce Integration of WinLIMS

Integrated Solution Enhances Laboratory Productivity

08-Jan-2001

NuGenesis Technologies Corporation and QSI announced a joint effort to integrate NuGenesis SDMS software with QSI's WinLIMS product. Laboratory scientists and IT professionals face significant challenges in their efforts to aggregate, validate, and trace enormous amounts of data generated by ...

more

Trizivir Approved in the European Union

05-Jan-2001

BioChem Pharma Inc. (NASDAQ: BCHE; TSE: BCH) announced today that its partner, GlaxoSmithKline plc, has received approval from the European Commission to market Trizivir, the new triple combination tablet, for the treatment of HIV-infected adults, in all the 15 member states of the European ...

more

Shell: Aviation fuel additive trial begins in search of environmental and economic benefits

05-Jan-2001

Shell Aviation, together with KLM Royal Dutch Airlines and BetzDearborn – a division of Hercules Incorporated, has during the last month, commenced a flight trial of a jet fuel performance-enhancing additive. The trial, the first of its kind, aims to demonstrate that using this additive in jet ...

more

Shire Pharmaceuticals: Anagrelide granted orphan drug status in EU

04-Jan-2001

Shire Pharmaceuticals Group plc (LSE: SHP.L, NASDAQ: SHPGY) announces that the European Commission has granted orphan designation to anagrelide for the treatment of essential thrombocythaemia. This designation covers the EU, plus Norway and Iceland, and confers up to 10 years market exclusivity ...

more

SYNOPSYS LAUNCHES A NEW CHEMISTRY-AWARE GRID CONTROL

02-Jan-2001

Synopsys Scientific Systems, a subsidiary of Pharmacopeia, Inc., announces the launch of its new Accord Grid Control. This latest addition to Synopsys' range of software development tools for chemistry allows developers to display and manipulate chemical objects in a grid format alongside ...

more

US FDA approves Novartis' Starlix®

27-Dec-2000

Novartis announced today that the US Food and Drug Administration (FDA) has granted marketing approval for Starlix® (nateglinide), the first in a new class of oral antidiabetic drugs that restores early insulin secretion, a fundamental defect in type 2 diabetes. It is indicated for use as both ...

more

Tecan introduces first fully automated BSE testing platform

22-Dec-2000

Doubles output in lab testing for “mad cow” disease at agreed laboratories; reduces bottlenecks in European markets, where BSE testing of beef will be required before sale Hombrechtikon (Zurich), Switzerland, 15 December 2000 – Tecan, a leading global provider of laboratory automation ...

more

Chrysler PT Cruiser: Paint coat from BASF

22-Dec-2000

Starting in spring 2001 the Graz, Austria, site of Eurostar, a DaimlerChrysler company, will manufacture the new Chrysler PT Cruiser. BASF Coatings is the sole supplier of coatings used to paint this vehicle, of which Theodore Cunningham, DaimlerChrysler's Executive Vice President International, ...

more

Page 135 From 135
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE